Good morning.

The Fast FiveBig Tech’s earnings week is make-or-break for rally, AI stock enthusiasm heats back up, oil tops $107 per barrel, path cleared for Trump's Fed pick, and US Mint buys drug cartel gold and sells it as ‘American’…

📌 Louis Navellier: Don't buy OR sell another AI stock… According to Louis, a massive reset is coming in an obscure corner of the AI market. This $100 trillion disruption could send some of the world's biggest AI stocks… and one off-the-radar stock soaring… starting now. Go here for details and Louis' new pick »
(from InvestorPlace)

  • Today:
    None watched

  • Tomorrow:
    Consumer Confidence, 10:00A

Your 5-minute briefing for Monday, Apr 27:

BEFORE THE OPEN

As of market close 4/24/2026. Bitcoin as of 4/26/2026.

Pre-Market:

Market Wrap:

  • Futures lower Dow -130, S&P -0.3%, Nasdaq -0.3%

  • Iran talks stalled with no meetings planned

  • Strait tensions rise after ship seizures

  • Oil higher WTI ~$96 on supply concerns

  • Big week ahead Fed decision and megacap earnings

  • Markets at record highs despite geopolitical risk

  • April strong S&P +9%, Nasdaq +15%, Dow +6%

EARNINGS

Here’s what we’re watching this week:

Trump Admin to Pump $1 Billion Into
This "Off-the-Radar" AI Stock

The US government pumped more than $1 billion into Intel. The stock popped 128%.

It pumped $400 million into MP Materials. The stock popped 200%.

It bought 10% of Trilogy Metals. The stock popped 500%.

And now, Trump has chosen this AI stock for a $1 billion payday.

- a sponsored message from InvestorPlace -

HEADLINES

Wall Street’s biggest tech stocks have carried the S&P 500 to record highs even as the war in Iran continues. Now, earnings from a handful of them this week will give investors a read on whether this rally is sustainable.

This gold comes from a Colombian drug cartel mine. It should never end up at the US Mint. But it does.

  • Oil jumps, stock futures slip as US-Iran talks stall (more)

  • Security scare and stalled Iran talks (more)

  • Tillis will support Warsh, clearing way for Trump's Fed pick (more)

  • A British king tries to stop another historic break with America (more)

  • AI stock enthusiasm heats back up (more)

  • US consumer sentiment slumps to record low in April (more)

  • Brent oil tops $107 per barrel after Iran peace talks stall (more)

  • Wall Street is sorting software companies into winners and losers (more)

  • Musk vies to turn X into Super App with banking tool near launch (more)

  • iHeartMedia holds merger talks with Sirius XM (more)

  • Saudi sovereign wealth fund to partner again with Live Nation (more)

  • BofA's 'sleep like a baby' portfolio having best year since 1933 (more)

  • Jane Street's $40B trading haul tops rivals (more)

DEALFLOW

M+A | Investments

  • Sun Pharma to acquire US-listed Organon in $12B deal

  • Valitana receives growth equity investment from FTV Capital

VC

  • QumulusAI, a GPU-powered cloud infrastructure for AI, received a $45M convertible note facility from ATW Partners

  • Minish Technology, a dental health-tech company, raised $22M in funding

  • Iridius, a compliance-by-design AI platform for regulated workflow execution, raised $8.6M in Seed funding

CRYPTO

  • Trump’s crypto pep talk can’t stop his memecoin’s deep slide (more)

  • Bitcoin’s stealth rally has traders setting sights on $80K (more)

  • Why DeFi isn't dead despite massive exploits and $13B investor exodus (more)

BULLISH BITES

📈 The AI stocks about to become worthless (and one that isn't). *

🚨 Everything we know about the D.C. correspondents’ dinner shooter.

⚖️ What's at stake in the Elon Musk-Sam Altman trial.

🏀 The Chinese sports brand taking on Nike and Adidas.

🤑 Warhol is out, Gulfstreams are in: The superrich are souring on art.

DAILY SHARES

*sponsored message

Disclaimer: Market Briefing© is a news publisher. All statements and expressions herein are the sole opinions of the authors or paid advertisers. The information, tools, and material presented are provided for informational purposes only, are not financial advice, and are not to be used or considered as an offer to buy or sell securities; and the publisher does not guarantee their accuracy or reliability. Please conduct your own research and consult an independent financial adviser before making any investments. Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. Assets mentioned may be owned by members of the Market Briefing team.

Reply

Avatar

or to participate

Keep Reading